Effectiveness and Safety of Mirikizumab after switching from Ustekinumab in patients with moderate to severe Crohn's disease: results from a long-term extension study

被引：0

作者：

D'Haens, G. ^{[1
]}

Laharie, D. ^{[2
,3
]}

Dulai, P. S. ^{[4
]}

Seibold, F. ^{[5
]}

Siegmund, B. ^{[6
]}

Abraham, B. ^{[7
,8
,9
]}

Malter, L. ^{[10
]}

Protic, M. ^{[11
]}

Morris, N. ^{[11
]}

Hozak, R. R. ^{[11
]}

Moses, R. E. ^{[11
]}

Lopes, M. Ugolini ^{[11
]}

Durand, F. ^{[11
]}

Yu, G. ^{[11
]}

Vermeire, S. ^{[12
]}

机构：

[1] Amsterdam Univ Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands

[2] Hop Haut Leveque, CHU Bordeaux, Serv Hepatogastroenterol, Bordeaux, France

[3] Univ Hosp Bordeaux, Digest Oncol Dept, Bordeaux, France

[4] Univ Calif San Diego, Div Gastroenterol, Los Angeles, CA 90089 USA

[5] Crohn Colitis Zentrum Intesto, Lindenhofspital, Bern, Switzerland

[6] Charite, Med Dept, Div Gastroenterol Infectiol & Rheumatol, Berlin, Germany

[7] Houston Methodist Hosp, Houston Methodist Gastroenterol Associates, Houston, TX USA

[8] Houston Methodist Acad Inst, Dept Med, Houston, TX USA

[9] Weill Cornell Med Coll, Dept Med, New York, NY USA

[10] NYU Langone Hlth, Div Gastroenterol, Dept Med, New York, NY USA

[11] Eli Lilly & Co, Lilly Immunol, Indianapolis, IN USA

[12] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, KU Leuven, Dept Chron Dis & Metab, Leuven, Belgium

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.0085

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP046

引用

页码：i168 / i170

页数：3

共 50 条

[21] Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry
Iborra, Marisa
Beltran, Belen
Fernandez-Clotet, Agnes
Iglesias-Flores, Eva
Navarro, Pablo
Rivero, Montserrat
Gutierrez, Ana
Sierra-Ausin, Monica
Mesonero, Francisco
Ferreiro-Iglesias, Rocio
Hinojosa, Joaquin
Calvet, Xavier
Sicilia, Beatriz
Gonzalez-Munoza, Carlos
Antolin, Beatriz
Gonzalez-Vivo, Maria
Carbajo, Ana Y.
Garcia-Lopez, Santiago
Martin-Cardona, Albert
Suris, Gerard
Dolores Martin-Arranz, Maria
de Francisco, Ruth
Canete, Fiorella
Domenech, Eugeni
Nos, Pilar
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (06) : 1017 - 1030
[22] Real-world long-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA registry
Iborra Colomino, M. I.
Beltran, B.
Fernandez-Clotet, A.
Iglesias Flores, E.
Navarro, P.
Rivero, M.
Gutierrez, A.
Sierra-Ausin, M.
Mesonero, F.
Ferreiro-Iglesias, R.
Hinojosa, J.
Calvet, X.
Sicilia, B.
Gonzalez-Munoza, C.
Antolin, B.
Gonzalez Vivo, M.
Carbajo, A. Y.
Garcia, S.
Martin-Cardona, A.
Suris Marin, G.
Martin-Arranz, M. D.
De Francisco, R.
Canete, F.
Carlos, T.
Gomollon, F.
Lorente, R.
Rodriguez-Lago, I.
Fores-Bosch, A.
Bernardos, E.
Ramos, L.
Delgado, P.
Hernandez, A.
Van Domselaar, M.
Hervas, D.
Domenech, E.
Nos, P.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S458 - S460
[23] Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long-term extension results
Turner, Dan
Rosh, Joel R.
Cohen, Stanley A.
Griffiths, Anne M.
Hyams, Jeffrey S.
Kierkus, Jaroslaw
Adedokun, Omoniyi J.
Strauss, Richard
Kim, Lilianne
Volger, Sheri
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (02): : 315 - 324
[24] Effectiveness and safety of ustekinumab in Crohn's disease: short and long-term results of a multi-refractory cohort
Aparicio-Serrano, A.
Zamora Olaya, J. M.
Ortiz Chimbo, D. S.
Rodriguez Tirado, M. I.
Gomez Perez, A.
Soto Escribano, P.
Marin Pedrosa, S.
Iglesias Flores, E.
Benitez, J. M.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I351 - I352
[25] Long-Term Clinical Effectiveness of Ustekinumab in Patients With Crohn's Disease: A Retrospective Cohort Study
Ito, Takahiro
Maemoto, Atsuo
Katsurada, Takehiko
Tanaka, Hiroki
Motoya, Satoshi
Ueno, Nobuhiro
Fujiya, Mikihiro
Ashida, Toshifumi
Hirayama, Daisuke
Nakase, Hiroshi
CROHNS & COLITIS 360, 2020, 2 (04) : 1 - 9
[26] Effectiveness and safety of ustekinumab in Crohn's disease: short and long-term results of a multi-refractory cohort
Aparicio-Serrano, A.
Zamora Olaya, J. M.
Ortiz Chimbo, D. S.
Rodriguez Tirado, M. I.
Gomez Perez, A.
Soto Escribano, P.
Marin Pedrosa, S.
Iglesias Flores, E.
Benitez, J. M.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I351 - I352
[27] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS PATIENTS WITH DELAYED RESPONSE TO USTEKINUMAB INDUCTION: RESULTS FROM THE UNIFI 2-YEAR LONG-TERM EXTENSION
Abreu, Maria T.
Sands, Bruce E.
Leong, Rupert W.
Marano, Colleen W.
O'Brien, Christopher D.
Zhang, Hongyan
Zhou, Yiying
Johanns, Jewel
Rowbotham, David
Hisamatsu, Tadakazu
Arasaradnam, Ramesh P.
Scherl, Ellen J.
Danese, Silvio
Peyrin-Biroulet, Laurent
GASTROENTEROLOGY, 2020, 158 (06) : S1201 - S1201
[28] Efficacy and safety of long-term treatment with ustekinumab in moderate-severe ulcerative colitis patients with delayed response to ustekinumab induction: Results from UNIFI 2-year long-term extension
Sands, B. E.
Abreu, M. T.
Leong, R. W. L.
Marano, C.
O'Brien, C. D.
Zhang, H.
Zhou, Y.
Johanns, J.
Rowbotham, D.
Hisamatsu, T.
Arasaradnam, R. P.
Scherl, E.
Danese, S.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S476 - S477
[29] Long-term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
Kimball, A. B.
Papp, K. A.
Wasfi, Y.
Chan, D.
Bissonnette, R.
Sofen, H.
Yeilding, N.
Li, S.
Szapary, P. O.
Gordon, K. B.
BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 63 - 64
[30] Efficacy and Safety of Ustekinumab for Crohn's Disease Through 5 Years: Final Results From the IM-UNITI Long-Term Extension
Sandborn, William J.
Rutgeerts, Paul
Lynch, John
Rebuck, Rory
Wang, Yuhua
Zou, Bin
Gasink, Christopher
Adedokun, Omoniyi
Sands, Bruce E.
Hanauer, Stephen
Targan, Stephan
Ghosh, Subrata
de Villiers, Willem J. S.
Colombel, Jean-Frederic
Feagan, Brian G.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S324

← 1 2 3 4 5 →